Ticker

electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript

electroCore, Inc. (ECOR) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.4 per share a year ago.

Record f ull year 2025 net sales of $ 32.0 , an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness sales

The royalty company's structure shields investors from rising fuel and chemical costs that are squeezing conventional miners RBC Capital Markets has highlighted Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR), the London-listed mining royalty company, as one of the better-performing equities since the outbreak of war with Iran. The Canadian bank reiterated its 'outperform' rating and 175p price target…

ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference March 22-24 at the Ritz-Carlton in Laguna Niguel, California.